Yarrow Bioscience, Inc. (YARW) stock
YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.21+0.28 (+2.01%)
Close on Nov 17, 2026Market cap $37.94MP/E –Yield –
Earnings
Yarrow Bioscience's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2026
–
Adjusted EPS, Q3 FY2026
-$0.43
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Yarrow Bioscience's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 12, 2026before the open | – | – | -$0.43 | – | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 28, 2026after the close | – | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 30, 2025before the open | – | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 8, 2025before the open | $200.00K | +100.0% | -$0.20 | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 6, 2025before the open | $84.00K | +10.5% | -$0.28 | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 7, 2024before the open | $100.00K | 0.0% | -$0.29 | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 14, 2024before the open | $200.00K | +100.0% | -$0.22 | – | Release |
| Q1 FY2024ended Mar 31, 2024 | May 9, 2024before the open | $100.00K | 0.0% | -$0.15 | – | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 29, 2024before the open | $76.00K | +1166.7% | -$0.20 | -$0.18 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023before the open | $100.00K | -50.0% | -$2.01 | -$1.75 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023before the open | $100.00K | 0.0% | -$3.09 | -$2.82 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023after the close | $100.00K | -50.0% | -$1.74 | -$1.48 | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 9, 2023after the close | $6.00K | -99.7% | -$3.33 | -$2.97 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022after the close | $200.00K | -95.1% | -$0.16 | -$0.14 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 12, 2022before the open | $100.00K | – | -$0.15 | -$0.13 | Release |
| Q1 FY2022ended Mar 31, 2022 | May 12, 2022after the close | $200.00K | – | $0.08 | $0.10 | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 17, 2022before the open | $2.29M | – | -$0.22 | -$0.20 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021before the open | $4.10M | – | -$0.41 | -$0.36 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 6, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 26, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 5, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 6, 2020before the open | – | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 11, 2020before the open | – | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 3, 2020after the close | – | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Oct 31, 2019after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Yarrow Bioscience has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Yarrow Bioscience puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Yarrow Bioscience filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- Results
- Results
- Results
- Results
- Results
- Update
- Update
- Update
- Update
- Update
- Update
- Results
See a number that looks wrong?